BGA 007
Alternative Names: BGA-007Latest Information Update: 11 Feb 2022
At a glance
- Originator BIOGENERA
- Class Antineoplastics; Oligonucleotides
- Mechanism of Action Genetic transcription inhibitors; PLK4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 04 Feb 2022 Early research in Solid tumors in Italy (Parenteral) (Biogenera pipeline, February 2022)